Lipid-lowering drugs: who gets what?

被引：9

作者：

Durrington, PN ^{[1
]}

Illingworth, R ^{[1
]}

机构：

[1] Univ Manchester, Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England

来源：

CURRENT OPINION IN LIPIDOLOGY | 1998年 / 9卷 / 04期

关键词：

D O I：

10.1097/00041433-199808000-00001

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

引用

页码：289 / 294

页数：6

共 46 条

[41] THE EFFECTS OF FIBRATES ON LIPOPROTEIN AND HEMOSTATIC CORONARY RISK-FACTORS [J].

SCHONFELD, G .

ATHEROSCLEROSIS, 1994, 111 (02) :161-174

[42] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[43]

SMIT WAJ, 1995, AM J CARDIOL, V76, pA126

[44] Fish consumption, fish oil, lipids, and coronary heart disease [J].

Stone, NJ .

AMERICAN JOURNAL OF CLINICAL NUTRITION, 1997, 65 (04) :1083-1086

[45] ROLE OF OXIDIZED LOW-DENSITY-LIPOPROTEIN IN ATHEROGENESIS [J].

WITZTUM, JL ;

STEINBERG, D .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1785-1792

[46] Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels [J].

Zhong, SB ;

Sharp, DS ;

Grove, JS ;

Bruce, C ;

Yano, K ;

Curb, JD ;

Tall, AR .

JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (12) :2917-2923

← 1 2 3 4 5 →